[1]
Wild, C.P. The global cancer burden: necessity is the mother of prevention. Nat. Rev. Cancer, 2019, 19, 123-124.
[3]
Ferlay, J.; Colombet, M.; Soerjomataram, I.; Mathers, C.; Parkin, D.M.; Piñeros, M.; Znaor, A.; Bray, F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer, 2019, 144, 1941-1953.
[6]
Wild, C.P.; Weiderpass, E.; Stewart, B.W. World cancer report: cancer research for cancer prevention; International Agency for Research on Cancer: Lyon, 2020.
[9]
Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin., 2018, 68, 394-424.
[10]
Conforti, C.; Corneli, P.; Harwood, C.; Zalaudek, I. Evolving role of systemic therapies in non-melanoma skin cancer. Clin. Oncol. (R. Coll. Radiol.), 2019, 31, 759-768.
[11]
O’Neill, C.H.; Scoggins, C.R. Melanoma. J. Surg. Oncol., 2019, 120, 873-881.
[12]
Ahmad, A. Breast cancer statistics: recent trends. In: Breast Cancer Metastasis and Drug Resistance, Advances in Experimental Medicine and Biology book series; Ahmad, A., Ed.; Springer: Cham, 2019, Vol. 1152, pp. 1-7.
[13]
Amant, F.; Mirza, M.R.; Koskas, M.; Creutzberg, C.L. Cancer of the corpus uteri. Int. J. Gynaecol. Obstet., 2018, 143, 37-50.
[14]
Cervenka, B.; Pipkorn, P.; Fagan, J. .; et al. . Oral cavity cancer management guidelines for low-resource regions. Head Neck, 2019, 41, 799-812.
[15]
Yamaji, T.; Tsugane, S. Epidemiology of esophageal squamous cell carcinoma. In: Esophageal Squamous Cell Carcinoma; Ando, N., Ed.; Springer: Singapore, 2020, pp. 1-13.
[16]
Barta, J.A.; Powell, C.A.; Wisnivesky, J.P. Global epidemiology of lung cancer. Ann. Glob. Health, 2019, 85, 8.
[17]
GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet, 2017, 389, 1885-1906.
[18]
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study. Lancet, 2018, 392, 1923-1994.
[19]
Chatenoud, L.; Garavello, W.; Pagan, E.; Bertuccio, P.; Gallus, S.; La Vecchia, C. et al. . Laryngeal cancer mortality trends in European countries. Int. J. Cancer, 2016, 138, 833-842.
[20]
Dobruch, J.; Daneshmand, S.; Fisch, M.; Lotan, Y.; Noon, A.P.; Resnick, M.J.; Shariat, S.F.; Zlotta, A.R.; Boorjian, S.A. Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur. Urol., 2016, 69, 300-310.
[21]
Miranda-Filho, A.; Piñeros, M.; Soerjomataram, I.; Deltour, I.; Bray, F. Cancers of the brain and CNS: global patterns and trends in incidence. Neuro-oncol., 2017, 19, 270-280.
